A study by researchers shows the risk of heart disease and stroke increases with stress. As stressful periods increases, individual may face more heart attacks and strokes. Researchers found enhanced activeness in the amygdala part of the brain when an individual feels stress or emotion. Researchers linked this extra activeness in the amygdala to the development of strokes and heart attacks. The study data shows bone marrow receives signals to generate more white blood cells from metabolical active amygdala causing narrow and thickening of arteries, which is a risk factor for cardiovascular diseases.
Researchers say cardiovascular disease patient under high stress should consider stress risk reduction measures such as talking, exercise or stress buster training which can reduce risk by 50 percent in five years. Author the study is Dr. Ahmed Tawakol, a cardiologist from Massachusetts General Hospital, Boston and the study findings were published in The Lancet.
A study by researchers shows the risk of ovarian cancer among African-American women with the consumption of dairy products. A previous study presented to ESAD shows food products specific to animals increases the risk of type 2 diabetes. Researchers monitored consumption of food products such as dairy products, vitamin D, lactose and calcium in 1,146 African American women suffering with or without cancer. Researchers found that
The study findings were published in the British Journal of Cancer.
The new version of Medtronic's continuous glucose monitoring (CGM) iPro2 myLog mobile App is a combination of health and activity functionality of Fitbit and Medtronic. The new CGM is going to give an actionable and accurate health view by presenting blood sugar and physical activity levels in a single App to manage the diabetic condition in a better way.
This integration helps patients to know how patient's physical exercise impacts own blood sugar levels. The data can be shared with healthcare professionals also. The new CGM will be available in both Android (downloaded from Google Play) and iOS (downloaded from Apple App Store) versions. The new App contains
A study by researchers from the University of Basel, Switzerland shows the destruction of cancer cells with a combination of metformin (a drug for the treatment of diabetes) and syrosingopine hypertension treatment drug. Researchers conducted studies with a number of available drugs for the enhancement of anti-cancer action of metformin and finally found the syrosingopine drug. Researchers say the discovered treatment works only for the destruction of cancer cells.
Researchers successfully reduced enlargement of the liver in mice models suffering from malignant liver cancer. A number of tumor nodules (growth of abnormal tissue) were less in experiments with other animal models. Cancer cells require high energy for sustaining itself. Cancer cells die as the drug combination interrupt energy supply (through blood) to them. Lead author of the study is Michael Hall, University of Basel and the study findings were published in the journal Science Advances.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.